Introduction
MSA, DLB, sleep behavior disorder, Parkinson's disease, neurodegenerative diseases, synucleinopathies, PD, RBD, Prodromal, muscle atonia
DISORDER, PARKINSON'S DISEASE, NEURODEGENERATIVE DISEASES, DREAM ENACTMENT BEHAVIOR, SYNUCLEINOPATHY, DEMENTIA WITH LEWY BODIES, MULTIPLE SYSTEM ATROPHY, PATHOLOGY, EYE, STAGGERING
The North American Prodromal Synucleinopathy (NAPS) Consortium for Rapid Eye Movement (REM) sleep behavior disorder (RBD) was established to facilitate neuroprotective clinical trials for neurodegenerative diseases characterized by synuclein pathology. Such “synucleinopathies,” including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), affect ~2‐million people in the US, have a staggering economic footprint,RBD is a disorder characterized by a lack of muscle atonia during REM sleep and dream enactment behaviors,Building upon existing RBD research groups (e.g., the International RBD Study Group),